Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence (original) (raw)

• Fiore MC . Treating tobacco use and dependence: an introduction to the US Public Health Service Clinical Practice Guideline. Respir Care 2000; 45: 1196–1199.
  CAS PubMed Google Scholar
• Silagy C, Lancaster T, Stead L, Mant D, Fowler G . Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004; 3: CD000146.
  Google Scholar
• Hughes J, Stead L, Lancaster T . Antidepressants for smoking cessation. Cochrane Database Syst Rev 2003; 2: CD000031.
  Google Scholar
• Lerman C, Patterson F, Berrettini W . Treating tobacco dependence: state of the science and new directions. J Clin Oncol 2005; 23: 311–323.
  Article Google Scholar
• Lerman C, Jepson C, Wileyto EP, Epstein LH, Rukstalis M, Patterson F et al. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Neuropsychopharmacology 2005; in press.
• Johnstone EC, Yudkin PL, Hey K, Roberts SJ, Welch SJ, Murphy MF et al. Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. Pharmacogenetics 2004; 14: 83–90.
  Article CAS Google Scholar
• Lerman C, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Restine S et al. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial. Pharmacogenomics J 2004; 4: 184–192.
  Article CAS Google Scholar
• Swan GE, Valdes AM, Ring HZ, Khroyan TV, Jack LM, Ton CC et al. Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR. Pharmacogenomics J 2005; 5: 21–29.
  Article CAS Google Scholar
• Bockaert J, Roussignol G, Becamel C, Gavarini S, Joubert L, Dumuis A et al. GPCR-interacting proteins (GIPs): nature and functions. Biochem Soc Trans 2004; 32(Part 5): 851–855.
  Article CAS Google Scholar
• Bergson C, Levenson R, Goldman-Rakic PS, Lidow MS . Dopamine receptor-interacting proteins: the Ca(2+) connection in dopamine signaling. Trends Pharmacol Sci 2003; 24: 486–492.
  Article CAS Google Scholar
• Burgoyne RD, O'Callaghan DW, Hasdemir B, Haynes LP, Tepikin AV . Neuronal Ca2+-sensor proteins: multitalented regulators of neuronal function. Trends Neurosci 2004; 27: 203–209.
  Article CAS Google Scholar
• Kabbani N, Negyessy L, Lin R, Goldman-Rakic P, Levenson R . Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor. J Neurosci 2002; 22: 8476–8486.
  Article CAS Google Scholar
• Arinami T, Gao M, Hamaguchi H, Toru M . A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 1997; 6: 577–582.
  Article CAS Google Scholar
• Nisell M, Nomikos GG, Svensson TH . Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release. Pharmacol Toxicol 1994; 75: 348–352.
  Article CAS Google Scholar
• Ito K, Haga T, Lameh J, Sadee W . Sequestration of dopamine D2 receptors depends on coexpression of G-protein-coupled receptor kinases 2 or 5. Eur J Biochem 1999; 260: 112–119.
  Article CAS Google Scholar
• Iwata K, Ito K, Fukuzaki A, Inaki K, Haga T . Dynamin and rab5 regulate GRK2-dependent internalization of dopamine D2 receptors. Eur J Biochem 1999; 263: 596–602.
  Article CAS Google Scholar
• Redden DT, Shields PG, Epstein L, Wileyto EP, Zakharkin SO, Allison DB et al. Catechol-_O_-methyl-transferase functional polymorphism and nicotine dependence: an evaluation of nonreplicated results. Cancer Epidemiol Biomarkers Prev 2005; 14: 1384–1389.
  Article CAS Google Scholar
• Bierut LJ, Rice JP, Edenberg HJ, Goate A, Foroud T, Cloninger CR et al. Family-based study of the association of the dopamine D2 receptor gene (DRD2) with habitual smoking. Am J Med Genet 2000; 90: 299–302.
  Article CAS Google Scholar
• Spitz MR, Shi H, Yang F, Hudmon KS, Jiang H, Chamberlain RM et al. Case–control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst 1998; 90: 358–363.
  Article CAS Google Scholar
• Lerman C, Kaufmann V, Rukstalis M, Patterson F, Perkins K, Audrain-McGovern J et al. Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial. Ann Intern Med 2004; 140: 426–433.
  Article CAS Google Scholar
• Brown R, Burgess E, Sales S, Whiteley J . Reliability and validity of a smoking timeline follow-back interview. Psychol Addict Behav 1998; 12: 101–112.
  Article Google Scholar
• Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO . The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991; 86: 1119–1127.
  Article CAS Google Scholar
• Hughes JR, Keely JP, Niaura R, Ossip-Klein DJ, Richmond RL, Swan GE . Measure of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003; 5: 13–25.
  Article Google Scholar
• SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002; 4: 149–159.
• Mander AP . HAPIPF: STATA Module to Perform Haplotype Analysis. Boston College Statistical Software Component Archive. Department of Economics: Chestnut Hill, 2002.
  Google Scholar
• Mander AP . Haplotype analysis in population-based association studies. STATA J 2001; 1: 58–75.
  Article Google Scholar